Plasma cytokines in polycythemia vera: phenotypic correlates, prognostic relevance, and comparison with myelofibrosis
- PMID: 22965887
- DOI: 10.1002/ajh.23295
Plasma cytokines in polycythemia vera: phenotypic correlates, prognostic relevance, and comparison with myelofibrosis
Abstract
Plasma cytokine milieu is abnormal in primary myelofibrosis (PMF) and correlates with disease phenotype and prognosis. In this study, we show that several plasma cytokines are also abnormally expressed in polycythemia vera (PV; n = 65), compared to normal controls (n = 35), but with a significantly different pattern than that of PMF (n = 127). Direct phenotypic correlation in PV included levels of IL-12 with hematocrit; IL-1b, IL-2, IL-7, FGF-b, and HGF with leukocytosis; and IFN-α and IFN-γ with thrombocytosis. In univariate analysis, levels of 13 cytokines (out of 30 analyzed) correlated with survival but only MIP-1β remained significant on multivariable analysis that included the other cytokines as covariates. Increased level of MIP-1β (P < 0.01), older age (P < 0.01), and leukocytosis (P = 0.03) maintained their association with shortened survival, on multivariable analysis. This study provides preliminary observations that warrant a larger scale study and suggests the value of plasma cytokines as prognostic biomarkers in PV.
Copyright © 2012 Wiley Periodicals, Inc.
Similar articles
-
Polyclonal immunoglobulin free light chain levels predict survival in myeloid neoplasms.J Clin Oncol. 2012 Apr 1;30(10):1087-94. doi: 10.1200/JCO.2011.39.0310. Epub 2012 Feb 13. J Clin Oncol. 2012. PMID: 22331938
-
Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study.J Clin Oncol. 2011 Apr 1;29(10):1356-63. doi: 10.1200/JCO.2010.32.9490. Epub 2011 Feb 7. J Clin Oncol. 2011. PMID: 21300928
-
Associations and prognostic interactions between circulating levels of hepcidin, ferritin and inflammatory cytokines in primary myelofibrosis.Am J Hematol. 2013 Apr;88(4):312-6. doi: 10.1002/ajh.23406. Epub 2013 Feb 28. Am J Hematol. 2013. PMID: 23450619
-
Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).Pathol Biol (Paris). 2007 Mar;55(2):92-104. doi: 10.1016/j.patbio.2006.06.002. Epub 2006 Aug 21. Pathol Biol (Paris). 2007. PMID: 16919893 Review.
-
The impact of clinicopathological studies on staging and survival in essential thrombocythemia, chronic idiopathic myelofibrosis, and polycythemia rubra vera.Semin Thromb Hemost. 2006 Jun;32(4 Pt 2):362-71. doi: 10.1055/s-2006-942757. Semin Thromb Hemost. 2006. PMID: 16810612 Review.
Cited by
-
Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms.Front Immunol. 2021 Jun 1;12:683401. doi: 10.3389/fimmu.2021.683401. eCollection 2021. Front Immunol. 2021. PMID: 34140953 Free PMC article. Review.
-
Cytokine Profiling in Myeloproliferative Neoplasms: Overview on Phenotype Correlation, Outcome Prediction, and Role of Genetic Variants.Cells. 2020 Sep 21;9(9):2136. doi: 10.3390/cells9092136. Cells. 2020. PMID: 32967342 Free PMC article. Review.
-
Always stressed but never exhausted: how stem cells in myeloid neoplasms avoid extinction in inflammatory conditions.Blood. 2023 Jun 8;141(23):2797-2812. doi: 10.1182/blood.2022017152. Blood. 2023. PMID: 36947811 Free PMC article.
-
VEGF Regulation of Angiogenic Factors via Inflammatory Signaling in Myeloproliferative Neoplasms.Int J Mol Sci. 2021 Jun 22;22(13):6671. doi: 10.3390/ijms22136671. Int J Mol Sci. 2021. PMID: 34206393 Free PMC article.
-
Polycythaemia vera.Nat Rev Dis Primers. 2025 Apr 17;11(1):26. doi: 10.1038/s41572-025-00608-3. Nat Rev Dis Primers. 2025. PMID: 40246933 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources